Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-14-006670
Filing Date
2014-09-16
Accepted
2014-09-16 08:42:32
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12014a1_relmada.htm S-1/A 2748786
2 CONSENT LETTER fs12014a1ex23i_relmada.htm EX-23.1 1899
3 CONSENT OF VALUATION FIRM fs12014a1ex23ii_relmada.htm EX-23.2 3690
10 GRAPHIC image_001.gif GRAPHIC 2012
  Complete submission text file 0001213900-14-006670.txt   9601665

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE relm-20140630.xml EX-101.INS 1255079
5 XBRL SCHEMA FILE relm-20140630.xsd EX-101.SCH 64805
6 XBRL CALCULATION FILE relm-20140630_cal.xml EX-101.CAL 35445
7 XBRL DEFINITION FILE relm-20140630_def.xml EX-101.DEF 271712
8 XBRL LABEL FILE relm-20140630_lab.xml EX-101.LAB 532083
9 XBRL PRESENTATION FILE relm-20140630_pre.xml EX-101.PRE 391962
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-197109 | Film No.: 141104524
SIC: 2834 Pharmaceutical Preparations